While the makers of Ozempic have stated that their GLP-1 medication was not made to be used as a weight loss drug, nor should ...

The new Ozempic? Weight-loss pill Amycretin could be more effective than jabs - Those who took the pill lost around 13 per cent of their body weight over three months ...

Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss potential in people with overweight or ...

Amycretin, a new weight loss drug developed by Novo Nordisk, helped participants lose up to 24.3% of body weight in just 36 ...

Novo Nordisk's experimental drug amycretin shows promising results in early trials, aiding significant weight loss in ...

Results for weight-loss drug targeting amylin find similar efficacy across different doses and high rates of side effects, ...

An early study have found that people who received higher doses of amycretin as a weekly jab lost 24.3% of their body weight ...

A new daily weight loss pill has shown promising results in initial studies. Researchers say amycretin, which can be offered ...

And initial trials assessing a tablet form of the drug also showed promising results, with patients taking daily tablets ...

A NEW ‘Ozempic pill’ leads to faster weight loss than the popular ‘skinny jabs’, studies have suggested. The new weight loss medication, which can also be offered by ...

Novo Nordisk will begin phase 3 trials for amycretin in early 2026 following promising weight loss data and regulatory ...